Correlation Between Citius Pharmaceuticals and Eyenovia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citius Pharmaceuticals and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citius Pharmaceuticals and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citius Pharmaceuticals and Eyenovia, you can compare the effects of market volatilities on Citius Pharmaceuticals and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citius Pharmaceuticals with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citius Pharmaceuticals and Eyenovia.

Diversification Opportunities for Citius Pharmaceuticals and Eyenovia

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Citius and Eyenovia is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Citius Pharmaceuticals and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Citius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citius Pharmaceuticals are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Citius Pharmaceuticals i.e., Citius Pharmaceuticals and Eyenovia go up and down completely randomly.

Pair Corralation between Citius Pharmaceuticals and Eyenovia

Given the investment horizon of 90 days Citius Pharmaceuticals is expected to generate 0.71 times more return on investment than Eyenovia. However, Citius Pharmaceuticals is 1.41 times less risky than Eyenovia. It trades about -0.27 of its potential returns per unit of risk. Eyenovia is currently generating about -0.25 per unit of risk. If you would invest  1,012  in Citius Pharmaceuticals on August 31, 2024 and sell it today you would lose (652.00) from holding Citius Pharmaceuticals or give up 64.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Citius Pharmaceuticals  vs.  Eyenovia

 Performance 
       Timeline  
Citius Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Citius Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Eyenovia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eyenovia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Citius Pharmaceuticals and Eyenovia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citius Pharmaceuticals and Eyenovia

The main advantage of trading using opposite Citius Pharmaceuticals and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citius Pharmaceuticals position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.
The idea behind Citius Pharmaceuticals and Eyenovia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments